Trial intelligence / Profile preview

Comparison of NSAIDs versus once-daily tramadol for chronic non-malignant pain in older adults

2008-003596-46Phase 4Terminated

Sponsor
Policlinico Gemelli
Start
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of tramadol in Chronic non-cancer pain (CNCP) (2 arms), sponsored by Policlinico Gemelli. Primary endpoints: Primary tolerability and safety endpoint and Primary efficacy endpoint. Started Oct 2008; status: terminated.

02

Drugs

tramadol
03

Conditions

Chronic non-cancer pain (CNCP)

Beyond the preview

Go deeper on 2008-003596-46.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003596-46.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call